Antiinflammatory effects of a combined herbal preparation (RAH13) of Phellodendron amurense and Coptis chinensis in animal models of inflammation

Phytotherapy Research

Volumn 21, Issue 8, 2007, Pages 746-750

  Park, Eun Kyung ^a   Hae, In Rhee ^c   Jung, Hye Sook ^a   Seoung, Min Ju ^a   Lee, Yeon Ah ^b   Lee, Sang Hoon ^a   Hong, Seung Jae ^b   Yang, Hyung In ^a   Yoo, Myung Chul ^a   Kim, Kyoung Soo ^a  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c SK Chemicals   (South Korea)

Author keywords

Acetic acid induced capillary permeability; Coptis chinensis Franch (Ranunculaceae); Cotton pellet induced granuloma; Croton oil induced ear edema; Delayed type hypersensitivity (DTH); Phellodendron amurense Rupr. (Rutaceae)

Indexed keywords

ANTIINFLAMMATORY AGENT; CELECOXIB; COPTIS CHINENSIS EXTRACT; CROTON OIL; DEXAMETHASONE; OXAZOLONE; PHELLODENDRON AMURENSE EXTRACT; RAH 13; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG MIXTURE; EDEMA; EXTERNAL EAR; FEMALE; GRANULOMA; INFLAMMATION; MALE; MOUSE; NONHUMAN; RHIZOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COPTIS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; GRANULOMA; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; PHELLODENDRON; PHYTOTHERAPY; PLANT EXTRACTS; PYRAZOLES; SULFONAMIDES;

ANIMALIA; COPTIS CHINENSIS; GOSSYPIUM HIRSUTUM; PHELLODENDRON AMURENSE; RANUNCULACEAE; RUTACEAE;

EID: 34547678127     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2156     Document Type: Article

References (31)

1. Akhter MH, Sabir M, Bhide NK. 1977. Anti-inflammatory effect of berberine in rats injected locally with cholera toxin. Indian J Med Res 65: 133-141.
2. Amin AH, Subbaiah TV, Abbasi KM. 1969. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol 15: 1067-1076.
3. Anis KV, Kuttan G, Kuttan R. 1999. Role of berberine as an adjuvant response modifier during tumour therapy in mice. Pharm Pharmacol Commun 5: 697-700.
4. Blaylock BL, Newsom KK, Holladay SD, Shipp BK, Bartow TA, Mehendale HM. 1995. Topical exposure to chlordane reduces the contact hypersensitivity response to oxazolone in BALB/c mice. Toxicol Lett 81: 205-211.
5. Bova S, Padrini R, Goldman WF, Berman DM, Cargnelli G. 1992. On the mechanism of vasodilating action of berberine: possible role of inositol lipid signaling system. J Pharmacol Exp Ther 261: 318-323.
6. Grabbe S, Schwarz T. 1998. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19: 37-44.
7. Jia W, Gao WY, Tang L. 2003. Antidiabetic herbal drugs officially approved in China. Phytother Res 17: 1127-1134.
8. Jiangsu New Medical College. 1986. Zhongyao Dacidian (Encyclopaedia of ChineseTraditional medicine). The People's Publishing Company: Shanghai.
9. Kobayashi K, Kaneda K, Kasama T. 2001. Immunopathogenesis of delayed-type hypersensitivity. Microsc Res Tech 53: 241-245.
10. Kondoh H, Sato Y, Kanoh H. 1985. Arachidonic acid metabolism in cultured mouse keratinocytes. J Invest Dermatol 85: 64-69.
11. Kong WJ, Wei J, Abidi P et al. 2004. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10: 1344-1351.
12. Lee KH. 2000. Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr 3: 515-522.
13. Leng SH, Lu FE, Xu LJ. 2004. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 25: 496-502.
14. Lin SK, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG. 2004. Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol Pharmacol 66: 612-619.
15. Lipsky PE, Tao XL. 1997. A potential new treatment for rheumatoid arthritis: thunder god vine. Semin Arthritis Rheum 26: 713-723.
16. Mantri P, Witiak DT. 1994. Inhibition of cyclooxygenase and 5-lipoxygenase. Curr Med Chem 1: 328-355.
17. McColl SR, Hurst NP, Cleland LG. 1986. Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun 141: 399-404.
18. Mukherjee D, Nissen SE, Topol EJ. 2001. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286: 954-959.
19. Olajide OA, Makinde JM, Okpako DT, Awe SO. 2000. Studies on the anti-inflammatory and related pharmacological properties of the aqueous extract of Bridelia ferruginea stem bark. J Ethnopharmacol 71: 153-160.
20. Park JI, Shim JK, Do JW et al. 1999. Immune-stimulating properties of polysaccharides from Phellodendri cortex (Hwangbek). Glycoconj J 16: 247-252.
21. Pimentel-Muinos FX, Munoz-Fernandez MA, Fresno M. 1994. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J Immunol 152: 5714-5722.
22. Qin WH, Yang JW, Zhu GD. 1981. Tripterygium Wilfordii Hook F in systemic lupus erythematosus: report of 103 cases. Chin Med 94: 827-834.
23. Rang HP, Dale MM, Ritter JM. 1999. Textbook of Pharmacology. Churchill Livingstone: UK, 199-242.
24. Selye H. 1953. On the mechanism through which hydrocortisone affects the resistance of tissues to injury; an experimental study with the granuloma pouch technique. JAMA 152: 1207-1213.
25. Tsai CS, Ochillo RF, 1991. Pharmacological effects of berberine on the longitudinal muscle of the guinea-pig isolated ileum. Arch Int Pharmacodyn Ther 310: 116-131.
26. Uchiyama T, Kamikawa H, Ogita Z. 1989. Anti-ulcer effect of extract from phellodendri cortex. Yakugaku Zasshi 109: 672-676.
27. Wang YX, Zheng YM. 1997. Ionic mechanism responsible for prolongation of cardiac action-potential duration by berberine. J Cardiovasc Pharmacol 30: 214-222.
28. Warren KC. 1972. In Inflammation. Academic Press: New York, 203.
29. Winter CA, Risley EA, Nuss GW. 1962. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 111: 544-547.
30. Yesilada E, Tanaka S, Sezik E, Tabata M. 1988. Isolation of an anti-inflammatory principle from the fruit juice of Ecballium elaterium. J Nat Prod 51: 504-508.
31. Zhang B, He XL, Ding Y, Du GH. 2006. Gaultherin, a natural salicylate derivative from Gaultheria yunnanensis: Towards a better non-steroidal anti-inflammatory drug. Eur J Pharmacol 530: 166-171.